Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis.

Limaye AP, Green ML, Edmison BC, Stevens-Ayers T, Chatterton-Kirchmeier S, Geballe AP, Singh N, Boeckh M.

J Infect Dis. 2019 Jul 31;220(5):752-760. doi: 10.1093/infdis/jiz181.

PMID:
31112280
2.

Adaptation by copy number variation in monopartite viruses.

Bayer A, Brennan G, Geballe AP.

Curr Opin Virol. 2018 Dec;33:7-12. doi: 10.1016/j.coviro.2018.07.001. Epub 2018 Jul 14. Review.

PMID:
30015083
3.

Inhibition of vaccinia virus replication by nitazoxanide.

Hickson SE, Margineantu D, Hockenbery DM, Simon JA, Geballe AP.

Virology. 2018 May;518:398-405. doi: 10.1016/j.virol.2018.03.023. Epub 2018 Apr 3.

4.

Antagonism of the Protein Kinase R Pathway in Human Cells by Rhesus Cytomegalovirus.

Child SJ, Hickson SE, Bayer A, Malouli D, Früh K, Geballe AP.

J Virol. 2018 Feb 26;92(6). pii: e01793-17. doi: 10.1128/JVI.01793-17. Print 2018 Mar 15.

5.

A Single Amino Acid Dictates Protein Kinase R Susceptibility to Unrelated Viral Antagonists.

Carpentier KS, Esparo NM, Child SJ, Geballe AP.

PLoS Pathog. 2016 Oct 25;12(10):e1005966. doi: 10.1371/journal.ppat.1005966. eCollection 2016 Oct.

6.

The AIM2-like Receptors Are Dispensable for the Interferon Response to Intracellular DNA.

Gray EE, Winship D, Snyder JM, Child SJ, Geballe AP, Stetson DB.

Immunity. 2016 Aug 16;45(2):255-66. doi: 10.1016/j.immuni.2016.06.015. Epub 2016 Aug 2.

7.

Evolution-guided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals.

Daugherty MD, Schaller AM, Geballe AP, Malik HS.

Elife. 2016 May 31;5. pii: e14228. doi: 10.7554/eLife.14228.

8.

An Evolutionary View of the Arms Race between Protein Kinase R and Large DNA Viruses.

Carpentier KS, Geballe AP.

J Virol. 2016 Jan 20;90(7):3280-3. doi: 10.1128/JVI.01996-15. Review.

9.

Essential role of protein kinase R antagonism by TRS1 in human cytomegalovirus replication.

Braggin JE, Child SJ, Geballe AP.

Virology. 2016 Feb;489:75-85. doi: 10.1016/j.virol.2015.11.032. Epub 2015 Dec 21.

10.

Analysis of the role of autophagy inhibition by two complementary human cytomegalovirus BECN1/Beclin 1-binding proteins.

Mouna L, Hernandez E, Bonte D, Brost R, Amazit L, Delgui LR, Brune W, Geballe AP, Beau I, Esclatine A.

Autophagy. 2016;12(2):327-42. doi: 10.1080/15548627.2015.1125071.

11.
12.

Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.

Schleiss MR, Bierle CJ, Swanson EC, McVoy MA, Wang JB, Al-Mahdi Z, Geballe AP.

J Virol. 2015 Oct;89(19):9727-38. doi: 10.1128/JVI.01419-15. Epub 2015 Jul 15.

13.

Adaptive gene amplification as an intermediate step in the expansion of virus host range.

Brennan G, Kitzman JO, Rothenburg S, Shendure J, Geballe AP.

PLoS Pathog. 2014 Mar 13;10(3):e1004002. doi: 10.1371/journal.ppat.1004002. eCollection 2014 Mar.

14.

Double-stranded RNA binding by the human cytomegalovirus PKR antagonist TRS1.

Bierle CJ, Semmens KM, Geballe AP.

Virology. 2013 Jul 20;442(1):28-37. doi: 10.1016/j.virol.2013.03.024. Epub 2013 Apr 17.

15.

Antagonism of the protein kinase R pathway by the guinea pig cytomegalovirus US22-family gene gp145.

Bierle CJ, Schleiss MR, Geballe AP.

Virology. 2012 Nov 10;433(1):157-66. doi: 10.1016/j.virol.2012.08.005. Epub 2012 Aug 20.

16.

Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses.

Elde NC, Child SJ, Eickbush MT, Kitzman JO, Rogers KS, Shendure J, Geballe AP, Malik HS.

Cell. 2012 Aug 17;150(4):831-41. doi: 10.1016/j.cell.2012.05.049.

17.

Species specificity of protein kinase r antagonism by cytomegalovirus TRS1 genes.

Child SJ, Brennan G, Braggin JE, Geballe AP.

J Virol. 2012 Apr;86(7):3880-9. doi: 10.1128/JVI.06158-11. Epub 2012 Jan 25. Erratum in: J Virol. 2012 Nov;86(22):12470.

18.

Cytomegalovirus: pathogen, paradigm, and puzzle.

Boeckh M, Geballe AP.

J Clin Invest. 2011 May;121(5):1673-80. doi: 10.1172/JCI45449.

19.

The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro.

Gantt S, Carlsson J, Ikoma M, Gachelet E, Gray M, Geballe AP, Corey L, Casper C, Lagunoff M, Vieira J.

Antimicrob Agents Chemother. 2011 Jun;55(6):2696-703. doi: 10.1128/AAC.01295-10. Epub 2011 Mar 14.

20.

Association of human cytomegalovirus proteins IRS1 and TRS1 with the viral DNA polymerase accessory subunit UL44.

Strang BL, Geballe AP, Coen DM.

J Gen Virol. 2010 Sep;91(Pt 9):2167-75. doi: 10.1099/vir.0.022640-0. Epub 2010 May 5.

21.

Multifaceted evasion of the interferon response by cytomegalovirus.

Marshall EE, Geballe AP.

J Interferon Cytokine Res. 2009 Sep;29(9):609-19. doi: 10.1089/jir.2009.0064. Review.

22.

Essential role for either TRS1 or IRS1 in human cytomegalovirus replication.

Marshall EE, Bierle CJ, Brune W, Geballe AP.

J Virol. 2009 May;83(9):4112-20. doi: 10.1128/JVI.02489-08. Epub 2009 Feb 11.

23.

Binding and relocalization of protein kinase R by murine cytomegalovirus.

Child SJ, Geballe AP.

J Virol. 2009 Feb;83(4):1790-9. doi: 10.1128/JVI.01484-08. Epub 2008 Dec 10.

24.

Protein kinase R reveals an evolutionary model for defeating viral mimicry.

Elde NC, Child SJ, Geballe AP, Malik HS.

Nature. 2009 Jan 22;457(7228):485-9. doi: 10.1038/nature07529. Epub 2008 Nov 30.

25.

Cellular serine/threonine phosphatase activity during human cytomegalovirus infection.

Hakki M, Geballe AP.

Virology. 2008 Oct 25;380(2):255-63. doi: 10.1016/j.virol.2008.07.028. Epub 2008 Aug 30.

26.

her-2 upstream open reading frame effects on the use of downstream initiation codons.

Spevak CC, Park EH, Geballe AP, Pelletier J, Sachs MS.

Biochem Biophys Res Commun. 2006 Dec 1;350(4):834-41. Epub 2006 Oct 2.

27.

Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins.

Child SJ, Hanson LK, Brown CE, Janzen DM, Geballe AP.

J Virol. 2006 Oct;80(20):10173-80.

28.

Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1.

Hakki M, Marshall EE, De Niro KL, Geballe AP.

J Virol. 2006 Dec;80(23):11817-26. Epub 2006 Sep 20. Erratum in: J Virol. 2011 Dec;85(23):12837.

29.

Downstream control of upstream open reading frames.

Sachs MS, Geballe AP.

Genes Dev. 2006 Apr 15;20(8):915-21. No abstract available.

30.

Double-stranded RNA binding by human cytomegalovirus pTRS1.

Hakki M, Geballe AP.

J Virol. 2005 Jun;79(12):7311-8. Erratum in: J Virol. 2011 Dec;85(23):12836.

31.

Influenza A pneumonia presenting as progressive focal infiltrates in a stem cell transplant recipient.

Scott JD, Englund JA, Myerson D, Geballe AP.

J Clin Virol. 2004 Oct;31(2):96-9.

PMID:
15364264
32.

The effect of eukaryotic release factor depletion on translation termination in human cell lines.

Janzen DM, Geballe AP.

Nucleic Acids Res. 2004 Aug 23;32(15):4491-502. Print 2004.

33.

Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1.

Child SJ, Hakki M, De Niro KL, Geballe AP.

J Virol. 2004 Jan;78(1):197-205.

34.

Modulation of translation termination mechanisms by cis- and trans-acting factors.

Janzen DM, Geballe AP.

Cold Spring Harb Symp Quant Biol. 2001;66:459-67. Review. No abstract available.

PMID:
12762048
35.
36.

Biochemistry. Sense and sensitivity--controlling the ribosome.

Sachs MS, Geballe AP.

Science. 2002 Sep 13;297(5588):1820-1. No abstract available.

PMID:
12228706
37.

Interleukin-1-mediated inhibition of cytomegalovirus replication is due to increased IFN-beta production.

Randolph-Habecker J, Iwata M, Geballe AP, Jarrahian S, Torok-Storb B.

J Interferon Cytokine Res. 2002 Jul;22(7):765-72.

PMID:
12184914
38.
39.
40.

Differentiation of human cytomegalovirus genotypes in immunocompromised patients on the basis of UL4 gene polymorphisms.

Bar M, Shannon-Lowe C, Geballe AP.

J Infect Dis. 2001 Jan 15;183(2):218-225. Epub 2000 Dec 8.

PMID:
11110652
41.

Upstream open reading frames as regulators of mRNA translation.

Morris DR, Geballe AP.

Mol Cell Biol. 2000 Dec;20(23):8635-42. Review. No abstract available.

42.

Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts.

Landini MP, Lazzarotto T, Xu J, Geballe AP, Mocarski ES.

Biol Blood Marrow Transplant. 2000;6(2):100-8.

44.

Translational control by an upstream open reading frame in the HER-2/neu transcript.

Child SJ, Miller MK, Geballe AP.

J Biol Chem. 1999 Aug 20;274(34):24335-41.

45.

Cell type-dependent and -independent control of HER-2/neu translation.

Child SJ, Miller MK, Geballe AP.

Int J Biochem Cell Biol. 1999 Jan;31(1):201-13. Erratum in: Int J Biochem Cell Biol 1999 Aug;31(8):883-4.

PMID:
10216954
46.
48.

Inhibition of nascent-peptide release at translation termination.

Cao J, Geballe AP.

Mol Cell Biol. 1996 Dec;16(12):7109-14.

49.

Human immunodeficiency virus type-1 susceptible whole cell and microcell hybrids.

Harrington RD, Geballe AP.

Ann Clin Lab Sci. 1996 Nov-Dec;26(6):522-30.

PMID:
8908322
50.

Supplemental Content

Loading ...
Support Center